Trial Profile
A phase I study of topical myristyl nicotinate cream on human skin in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Myristyl nicotinate (Primary)
- Indications Skin cancer
- Focus Adverse reactions
- 26 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 May 2010 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 25 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.